BioSpace News Archive

On July the 8 th , Croma-Pharma GmbH (Croma) has stated that the company submitted the drug file of its botulinum toxin product to the German authority BfArM. The filing of the dossier stands for the next essential step towards Croma’s complete aesthetic portfolio in Europe, which already comprises of a comprehensive HA filler range, threads, PRP and skincare products. Croma has licensed the product from the Ko

JDRF, the leading global organization funding type 1 diabetes (T1D) research, and Tandem Diabetes Care (NASDAQ: TNDM), a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience, announce a new national partnership to help drive awareness and education on topics related to technology innovation, diabetes management, and healthcare for peo

ViralClear Pharmaceuticals, Inc. (ViralClear), supported by Albany Molecular Research Inc. , (AMRI), a leading global contract research, development, and manufacturing organization (CDMO), is undertaking research to investigate the potential of merimepodib to fight SARS-CoV-2, the virus that causes COVID-19, either as a stand-alone treatment or in combination with other antiviral agents or immune modulators. “As p

TALLC Corporation Inc. today announced that the United Kingdom Intellectual Property Office (IPO) has granted TALLC patent GB2561009 entitled “Non-ionic Block Copolymers and Pharmaceutical Compositions Derived Therefrom” the first in a series of SmartCelle ‘smart micelle’ patents covering this novel nanotechnology.

Notable, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, announced today that Joseph Wagner, PhD, has joined the company as Chief Scientific Officer

The American Pharmacists Association (APhA) and International Pharmaceutical Federation (FIP) stand with front-line pharmacists around the world who are caring for patients and rely heavily on the support of the World Health Organization (WHO) during the COVID-19 global crisis.

BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”) and its subsidiary, ViralClear Pharmaceuticals, Inc., today announced that it is partnering with Albany Molecular Research Inc., (AMRI), a leading global contract research, development and manufacturing organization (CDMO), for support in undertaking research to investigate the potential of merimepodib to fight SARS-CoV-2, the virus that causes COVID-19,

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.

Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, today announced it will be restating its previously issued audited consolidated financial statements for the twelve months ended December 31, 2018 and unaudited quarterly statements for the three and nine months ended September 30, 2019.

Otonomy, Inc., a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, announced that it has commenced an underwritten public offering of its common stock.